| 0 |
BLOOD HUMAN CHORIONIC GONADOTROPIN NEGATIVE |
1 |
0.5000 |
| 1 |
AICHMOPHOBIA |
1 |
0.5000 |
| 2 |
CHOLANGIOSARCOMA |
3 |
0.3750 |
| 3 |
OVARIAN HYPERSTIMULATION SYNDROME |
483 |
0.2070 |
| 4 |
OVULATION INDUCTION |
2 |
0.1538 |
| 5 |
ARTIFICIAL INSEMINATION |
1 |
0.1429 |
| 6 |
ULTRASOUND SCAN VAGINA ABNORMAL |
1 |
0.1429 |
| 7 |
OPTIC NERVE SHEATH MENINGIOMA |
3 |
0.1364 |
| 8 |
KAYSER-FLEISCHER RING |
1 |
0.1250 |
| 9 |
ASSISTED FERTILISATION |
1 |
0.1250 |
| 10 |
TRISOMY 22 |
2 |
0.1176 |
| 11 |
OVARIAN HAEMORRHAGE |
22 |
0.0928 |
| 12 |
POOR RESPONSE TO OVULATION INDUCTION |
1 |
0.0909 |
| 13 |
DECREASED EMBRYO VIABILITY |
2 |
0.0833 |
| 14 |
HYPOPITUITARISM FOETAL |
1 |
0.0769 |
| 15 |
VAGINAL CUFF DEHISCENCE |
2 |
0.0667 |
| 16 |
MULTIPLE PREGNANCY |
10 |
0.0559 |
| 17 |
OVARIAN ENLARGEMENT |
21 |
0.0548 |
| 18 |
DIMINISHED OVARIAN RESERVE |
1 |
0.0526 |
| 19 |
OVULATION DELAYED |
1 |
0.0476 |
| 20 |
PROGESTERONE INCREASED |
5 |
0.0450 |
| 21 |
VANISHING TWIN SYNDROME |
4 |
0.0449 |
| 22 |
FOREIGN BODY IN SKIN OR SUBCUTANEOUS TISSUE |
3 |
0.0435 |
| 23 |
SOFT TISSUE FOREIGN BODY |
1 |
0.0435 |
| 24 |
ENDOMETRIAL HYPOPLASIA |
1 |
0.0417 |
| 25 |
PREMATURE OVULATION |
3 |
0.0385 |
| 26 |
OVARIAN RUPTURE |
4 |
0.0342 |
| 27 |
TUBO-OVARIAN ABSCESS |
8 |
0.0328 |
| 28 |
OVARIAN ABSCESS |
5 |
0.0321 |
| 29 |
OVARIAN NECROSIS |
2 |
0.0317 |
| 30 |
HETEROTOPIC PREGNANCY |
2 |
0.0317 |
| 31 |
STREPTOCOCCAL IDENTIFICATION TEST POSITIVE |
1 |
0.0303 |
| 32 |
ADRENAL INSUFFICIENCY NEONATAL |
1 |
0.0294 |
| 33 |
BIOCHEMICAL PREGNANCY |
3 |
0.0278 |
| 34 |
BLOOD OESTROGEN INCREASED |
16 |
0.0272 |
| 35 |
HUMAN CHORIONIC GONADOTROPIN DECREASED |
3 |
0.0270 |
| 36 |
PELVIC FLUID COLLECTION |
18 |
0.0255 |
| 37 |
ADNEXAL TORSION |
8 |
0.0252 |
| 38 |
OVARIAN TORSION |
2 |
0.0241 |
| 39 |
HAEMOCONCENTRATION |
4 |
0.0231 |
| 40 |
OOPHORITIS |
3 |
0.0211 |
| 41 |
CEPHALO-PELVIC DISPROPORTION |
4 |
0.0200 |
| 42 |
KIDNEY ANGIOMYOLIPOMA |
1 |
0.0200 |
| 43 |
ADNEXA UTERI CYST |
3 |
0.0185 |
| 44 |
HUMAN CHORIONIC GONADOTROPIN POSITIVE |
1 |
0.0175 |
| 45 |
SEPTUM PELLUCIDUM AGENESIS |
1 |
0.0167 |
| 46 |
TWIN PREGNANCY |
14 |
0.0166 |
| 47 |
FAILED IN VITRO FERTILISATION |
1 |
0.0164 |
| 48 |
HYPOOSMOLAR STATE |
2 |
0.0163 |
| 49 |
NIPPLE ENLARGEMENT |
1 |
0.0161 |
| 50 |
ECTOPIC PREGNANCY TERMINATION |
1 |
0.0159 |
| 51 |
MELANODERMA |
3 |
0.0156 |
| 52 |
LEUKOPENIA NEONATAL |
1 |
0.0152 |
| 53 |
NONINFECTIVE OOPHORITIS |
1 |
0.0149 |
| 54 |
BLOOD HUMAN CHORIONIC GONADOTROPIN INCREASED |
3 |
0.0141 |
| 55 |
BLADDER TAMPONADE |
4 |
0.0132 |
| 56 |
BENIGN HYDATIDIFORM MOLE |
4 |
0.0121 |
| 57 |
OVARIAN DISORDER |
11 |
0.0117 |
| 58 |
PELVIC HAEMATOMA |
5 |
0.0113 |
| 59 |
HYDROSALPINX |
1 |
0.0109 |
| 60 |
REMOVAL OF FOREIGN BODY |
1 |
0.0109 |
| 61 |
CLINICALLY ISOLATED SYNDROME |
1 |
0.0105 |
| 62 |
BLOOD VISCOSITY ABNORMAL |
1 |
0.0105 |
| 63 |
ABORTION SPONTANEOUS INCOMPLETE |
1 |
0.0103 |
| 64 |
CONGENITAL CHOROID PLEXUS CYST |
3 |
0.0098 |
| 65 |
UTERINE HYPERSTIMULATION |
1 |
0.0098 |
| 66 |
ANOVULATORY CYCLE |
2 |
0.0097 |
| 67 |
MUCOCUTANEOUS TOXICITY |
1 |
0.0095 |
| 68 |
POOR QUALITY DEVICE USED |
91 |
0.0091 |
| 69 |
ABDOMINAL REBOUND TENDERNESS |
1 |
0.0089 |
| 70 |
SHIGELLA INFECTION |
1 |
0.0088 |
| 71 |
CEREBROSPINAL FLUID RETENTION |
1 |
0.0085 |
| 72 |
TESTICULAR NEOPLASM |
1 |
0.0085 |
| 73 |
DYSPLASTIC NAEVUS |
3 |
0.0083 |
| 74 |
SALPINGO-OOPHORITIS |
1 |
0.0082 |
| 75 |
BLOOD LUTEINISING HORMONE INCREASED |
2 |
0.0081 |
| 76 |
HEPATO-LENTICULAR DEGENERATION |
1 |
0.0079 |
| 77 |
RUPTURED ECTOPIC PREGNANCY |
6 |
0.0077 |
| 78 |
MATERNAL EXPOSURE BEFORE PREGNANCY |
51 |
0.0075 |
| 79 |
APPLICATION SITE NODULE |
1 |
0.0073 |
| 80 |
BONE FISSURE |
3 |
0.0072 |
| 81 |
VACTERL SYNDROME |
1 |
0.0071 |
| 82 |
HAEMORRHAGIC ASCITES |
2 |
0.0070 |
| 83 |
HAEMORRHAGIC OVARIAN CYST |
4 |
0.0070 |
| 84 |
ENDOMETRIAL ATROPHY |
1 |
0.0069 |
| 85 |
ACUTE ABDOMEN |
10 |
0.0068 |
| 86 |
OESTRADIOL INCREASED |
2 |
0.0066 |
| 87 |
POLYCYSTIC OVARIES |
10 |
0.0064 |
| 88 |
PROGESTERONE DECREASED |
2 |
0.0064 |
| 89 |
AMNIOCENTESIS ABNORMAL |
1 |
0.0064 |
| 90 |
OESTRADIOL DECREASED |
2 |
0.0062 |
| 91 |
ECTOPIC PREGNANCY |
19 |
0.0062 |
| 92 |
CEREBELLAR HYPOPLASIA |
1 |
0.0060 |
| 93 |
DRUG EXPOSURE BEFORE PREGNANCY |
6 |
0.0059 |
| 94 |
FOETAL CHROMOSOME ABNORMALITY |
1 |
0.0059 |
| 95 |
SELECTIVE ABORTION |
1 |
0.0057 |
| 96 |
PUNCTURE SITE HAEMORRHAGE |
4 |
0.0056 |
| 97 |
PROCEDURAL FAILURE |
1 |
0.0056 |
| 98 |
OVARIAN FAILURE |
3 |
0.0056 |
| 99 |
TINEA VERSICOLOUR |
2 |
0.0056 |
| 100 |
IN VITRO FERTILISATION |
1 |
0.0055 |
| 101 |
ADNEXA UTERI PAIN |
7 |
0.0055 |
| 102 |
MYCOBACTERIUM FORTUITUM INFECTION |
1 |
0.0054 |
| 103 |
LID SULCUS DEEPENED |
2 |
0.0054 |
| 104 |
HEPATIC VASCULAR THROMBOSIS |
1 |
0.0052 |
| 105 |
INJECTION SITE ECZEMA |
1 |
0.0052 |
| 106 |
CONGENITAL PULMONARY HYPERTENSION |
1 |
0.0052 |
| 107 |
HAEMOPERITONEUM |
4 |
0.0050 |
| 108 |
OVULATION PAIN |
1 |
0.0048 |
| 109 |
THREATENED LABOUR |
2 |
0.0047 |
| 110 |
CHORIORETINITIS |
3 |
0.0047 |
| 111 |
PLACENTA ACCRETA |
1 |
0.0046 |
| 112 |
RENAL HYPOPLASIA |
1 |
0.0046 |
| 113 |
PLACENTAL INFARCTION |
1 |
0.0045 |
| 114 |
CYST RUPTURE |
3 |
0.0044 |
| 115 |
PREGNANCY TEST FALSE POSITIVE |
2 |
0.0043 |
| 116 |
INTRA-ABDOMINAL HAEMORRHAGE |
10 |
0.0042 |
| 117 |
ARNOLD-CHIARI MALFORMATION |
4 |
0.0042 |
| 118 |
PELVIC ADHESIONS |
1 |
0.0042 |
| 119 |
ABORTION THREATENED |
2 |
0.0040 |
| 120 |
OVARIAN CYST RUPTURED |
5 |
0.0039 |
| 121 |
EPILEPTIC AURA |
1 |
0.0039 |
| 122 |
CONGENITAL HYPOTHYROIDISM |
1 |
0.0039 |
| 123 |
EXPOSURE TO CONTAMINATED DEVICE |
1 |
0.0038 |
| 124 |
UTERINE CONTRACTIONS ABNORMAL |
1 |
0.0037 |
| 125 |
CLINODACTYLY |
1 |
0.0036 |
| 126 |
THYROIDITIS SUBACUTE |
1 |
0.0034 |
| 127 |
SHORTENED CERVIX |
1 |
0.0034 |
| 128 |
FALLOPIAN TUBE DISORDER |
1 |
0.0034 |
| 129 |
EAR TUBE INSERTION |
1 |
0.0034 |
| 130 |
RETAINED PLACENTA OR MEMBRANES |
1 |
0.0033 |
| 131 |
HYPNAGOGIC HALLUCINATION |
1 |
0.0033 |
| 132 |
NIPPLE DISORDER |
2 |
0.0032 |
| 133 |
PROTEIN DEFICIENCY |
1 |
0.0032 |
| 134 |
PELVIC DISCOMFORT |
3 |
0.0032 |
| 135 |
FOETAL CARDIAC DISORDER |
1 |
0.0032 |
| 136 |
ABORTION MISSED |
4 |
0.0031 |
| 137 |
SALPINGITIS |
1 |
0.0031 |
| 138 |
RED BLOOD CELL SCHISTOCYTES PRESENT |
1 |
0.0031 |
| 139 |
ALLERGIC RESPIRATORY SYMPTOM |
1 |
0.0030 |
| 140 |
SPORTS INJURY |
1 |
0.0029 |
| 141 |
WAIST CIRCUMFERENCE INCREASED |
3 |
0.0029 |
| 142 |
NEONATAL INFECTION |
1 |
0.0029 |
| 143 |
ASCITES |
85 |
0.0029 |
| 144 |
SPINE MALFORMATION |
1 |
0.0029 |
| 145 |
LEIOMYOMA |
2 |
0.0029 |
| 146 |
JOINT ABSCESS |
1 |
0.0029 |
| 147 |
OVERLAP SYNDROME |
2 |
0.0029 |
| 148 |
GASTROINTESTINAL MICROORGANISM OVERGROWTH |
1 |
0.0028 |
| 149 |
INTRA-ABDOMINAL FLUID COLLECTION |
5 |
0.0028 |
| 150 |
ENTEROBACTER SEPSIS |
1 |
0.0027 |
| 151 |
LOCAL REACTION |
2 |
0.0027 |
| 152 |
COMPLICATION OF PREGNANCY |
2 |
0.0026 |
| 153 |
TRISOMY 18 |
1 |
0.0026 |
| 154 |
HYPERCOAGULATION |
5 |
0.0026 |
| 155 |
NEUROBLASTOMA |
1 |
0.0026 |
| 156 |
AZOOSPERMIA |
1 |
0.0026 |
| 157 |
POLYCYSTIC OVARIAN SYNDROME |
1 |
0.0026 |
| 158 |
BLOOD FOLLICLE STIMULATING HORMONE INCREASED |
1 |
0.0026 |
| 159 |
LIPOEDEMA |
1 |
0.0025 |
| 160 |
BLIGHTED OVUM |
1 |
0.0025 |
| 161 |
ENDOMETRIAL HYPERTROPHY |
1 |
0.0025 |
| 162 |
INTRA-UTERINE DEATH |
4 |
0.0025 |
| 163 |
URETERAL DISORDER |
1 |
0.0024 |
| 164 |
GASTROINTESTINAL ANGIODYSPLASIA |
1 |
0.0024 |
| 165 |
THROMBOCYTOPENIA NEONATAL |
1 |
0.0024 |
| 166 |
SUPERFICIAL VEIN THROMBOSIS |
2 |
0.0024 |
| 167 |
CHOROIDAL NEOVASCULARISATION |
2 |
0.0023 |
| 168 |
HUMAN CHORIONIC GONADOTROPIN INCREASED |
2 |
0.0022 |
| 169 |
FOETAL HEART RATE ABNORMAL |
2 |
0.0022 |
| 170 |
PELVIC INFECTION |
1 |
0.0022 |
| 171 |
MASTOCYTOSIS |
1 |
0.0021 |
| 172 |
PLACENTAL DISORDER |
2 |
0.0021 |
| 173 |
DRAINAGE |
1 |
0.0020 |
| 174 |
MESENTERIC VEIN THROMBOSIS |
2 |
0.0020 |
| 175 |
INFERTILITY |
3 |
0.0020 |
| 176 |
CERVICAL INCOMPETENCE |
1 |
0.0020 |
| 177 |
TENSION |
12 |
0.0020 |
| 178 |
NIPPLE PAIN |
4 |
0.0020 |
| 179 |
SPINA BIFIDA |
4 |
0.0019 |
| 180 |
DEVICE USE CONFUSION |
1 |
0.0019 |
| 181 |
HYPERLIPASAEMIA |
1 |
0.0019 |
| 182 |
RETINAL VASCULAR THROMBOSIS |
1 |
0.0019 |
| 183 |
UMBILICAL CORD ABNORMALITY |
1 |
0.0019 |
| 184 |
ANAL ATRESIA |
1 |
0.0019 |
| 185 |
MORNING SICKNESS |
1 |
0.0018 |
| 186 |
HAEMORRHAGIC INFARCTION |
1 |
0.0018 |
| 187 |
CYTOGENETIC ABNORMALITY |
2 |
0.0018 |
| 188 |
ANENCEPHALY |
1 |
0.0018 |
| 189 |
BREAST DISCHARGE |
3 |
0.0017 |
| 190 |
JUGULAR VEIN THROMBOSIS |
3 |
0.0017 |
| 191 |
CIRCUMSTANCE OR INFORMATION CAPABLE OF LEADING TO DEVICE USE ERROR |
4 |
0.0017 |
| 192 |
CEREBRAL VENOUS THROMBOSIS |
3 |
0.0017 |
| 193 |
ADENOCARCINOMA OF COLON |
3 |
0.0016 |
| 194 |
HYPOPROTEINAEMIA |
3 |
0.0016 |
| 195 |
ENDOMETRIAL ADENOCARCINOMA |
1 |
0.0016 |
| 196 |
DRUG LEVEL DECREASED |
16 |
0.0016 |
| 197 |
EXTREMITY CONTRACTURE |
1 |
0.0016 |
| 198 |
ABORTION SPONTANEOUS |
62 |
0.0015 |
| 199 |
CIRCUMSTANCE OR INFORMATION CAPABLE OF LEADING TO MEDICATION ERROR |
52 |
0.0015 |
| 200 |
GASTROINTESTINAL MUCOSAL DISORDER |
1 |
0.0015 |
| 201 |
BREAST SWELLING |
4 |
0.0015 |
| 202 |
EFFUSION |
2 |
0.0015 |
| 203 |
CHRONIC FATIGUE SYNDROME |
2 |
0.0014 |
| 204 |
POOR QUALITY PRODUCT ADMINISTERED |
15 |
0.0014 |
| 205 |
CONGENITAL HYDRONEPHROSIS |
1 |
0.0014 |
| 206 |
GRAFT VERSUS HOST DISEASE IN LIVER |
1 |
0.0014 |
| 207 |
PELVIC VENOUS THROMBOSIS |
2 |
0.0014 |
| 208 |
ABDOMINAL DISTENSION |
144 |
0.0014 |
| 209 |
HEMIANOPIA HOMONYMOUS |
1 |
0.0014 |
| 210 |
OVARIAN MASS |
1 |
0.0014 |
| 211 |
BLOOD LOSS ANAEMIA |
3 |
0.0013 |
| 212 |
RUBBER SENSITIVITY |
2 |
0.0013 |
| 213 |
PRESCRIPTION FORM TAMPERING |
1 |
0.0013 |
| 214 |
METAPNEUMOVIRUS INFECTION |
1 |
0.0013 |
| 215 |
PLACENTA PRAEVIA |
1 |
0.0013 |
| 216 |
AORTIC DISORDER |
1 |
0.0013 |
| 217 |
ABDOMINAL PAIN LOWER |
32 |
0.0013 |
| 218 |
PRODUCT LEAKAGE |
7 |
0.0012 |
| 219 |
HEPATITIS VIRAL |
1 |
0.0012 |
| 220 |
DIABETES INSIPIDUS |
3 |
0.0012 |
| 221 |
SEPSIS NEONATAL |
1 |
0.0012 |
| 222 |
HYDROTHORAX |
1 |
0.0012 |
| 223 |
OVARIAN CYST |
12 |
0.0012 |
| 224 |
COVID-19 IMMUNISATION |
1 |
0.0012 |
| 225 |
CULTURE POSITIVE |
1 |
0.0012 |
| 226 |
AMAUROSIS |
1 |
0.0012 |
| 227 |
CAROTID ARTERY THROMBOSIS |
1 |
0.0012 |
| 228 |
INTENTIONAL DEVICE USE ISSUE |
1 |
0.0012 |
| 229 |
CORONARY ARTERY DISSECTION |
1 |
0.0012 |
| 230 |
PATERNAL EXPOSURE DURING PREGNANCY |
1 |
0.0012 |
| 231 |
ABSCESS DRAINAGE |
1 |
0.0012 |
| 232 |
FOETAL GROWTH RESTRICTION |
7 |
0.0012 |
| 233 |
AXIAL SPONDYLOARTHRITIS |
1 |
0.0011 |
| 234 |
LARGE FOR DATES BABY |
1 |
0.0011 |
| 235 |
UTERINE POLYP |
2 |
0.0011 |
| 236 |
IMPLANT SITE PRURITUS |
1 |
0.0011 |
| 237 |
PRODUCT OUTER PACKAGING ISSUE |
1 |
0.0011 |
| 238 |
NORMAL NEWBORN |
6 |
0.0011 |
| 239 |
MENINGIOMA BENIGN |
1 |
0.0011 |
| 240 |
ADVERSE FOOD REACTION |
1 |
0.0011 |
| 241 |
EXPOSURE VIA DIRECT CONTACT |
1 |
0.0011 |
| 242 |
ENDOMETRIOSIS |
5 |
0.0010 |
| 243 |
DRUG ADMINISTERED IN WRONG DEVICE |
1 |
0.0010 |
| 244 |
HEMIANOPIA |
1 |
0.0010 |
| 245 |
SMALL FOR DATES BABY |
5 |
0.0010 |
| 246 |
THYROIDITIS |
3 |
0.0010 |
| 247 |
POLYHYDRAMNIOS |
1 |
0.0010 |
| 248 |
STEROID WITHDRAWAL SYNDROME |
1 |
0.0010 |
| 249 |
NO ADVERSE EVENT |
176 |
0.0010 |
| 250 |
VENOUS THROMBOSIS LIMB |
2 |
0.0010 |
| 251 |
GENERALISED TONIC-CLONIC SEIZURE |
16 |
0.0010 |
| 252 |
NEEDLE ISSUE |
28 |
0.0010 |
| 253 |
NON-CARDIOGENIC PULMONARY OEDEMA |
1 |
0.0009 |
| 254 |
HYDROCELE |
1 |
0.0009 |
| 255 |
INTRACRANIAL VENOUS SINUS THROMBOSIS |
1 |
0.0009 |
| 256 |
CONGENITAL CENTRAL NERVOUS SYSTEM ANOMALY |
1 |
0.0009 |
| 257 |
FOETAL MALFORMATION |
1 |
0.0009 |
| 258 |
INCORRECT DOSE ADMINISTERED BY DEVICE |
24 |
0.0009 |
| 259 |
RIGHT VENTRICULAR DYSFUNCTION |
1 |
0.0009 |
| 260 |
CLEFT LIP AND PALATE |
1 |
0.0009 |
| 261 |
MOANING |
1 |
0.0009 |
| 262 |
HAEMATOCRIT INCREASED |
2 |
0.0009 |
| 263 |
GLOMERULONEPHRITIS MEMBRANOUS |
1 |
0.0009 |
| 264 |
DEVICE DISPENSING ERROR |
1 |
0.0008 |
| 265 |
PRODUCT PACKAGING ISSUE |
8 |
0.0008 |
| 266 |
PREMATURE RUPTURE OF MEMBRANES |
2 |
0.0008 |
| 267 |
HYPERTHYROIDISM |
12 |
0.0008 |
| 268 |
PELVIC PAIN |
15 |
0.0008 |
| 269 |
OLIGURIA |
5 |
0.0008 |
| 270 |
PLEURAL EFFUSION |
49 |
0.0008 |
| 271 |
VAGINAL ODOUR |
1 |
0.0008 |
| 272 |
TRISOMY 21 |
1 |
0.0008 |
| 273 |
HYPERAESTHESIA TEETH |
1 |
0.0008 |
| 274 |
RETINAL ARTERY OCCLUSION |
2 |
0.0008 |
| 275 |
DERMATOMYOSITIS |
2 |
0.0008 |
| 276 |
PRODUCT CONTAMINATION PHYSICAL |
2 |
0.0008 |
| 277 |
GESTATIONAL HYPERTENSION |
1 |
0.0008 |
| 278 |
CAESAREAN SECTION |
9 |
0.0008 |
| 279 |
CALCIUM DEFICIENCY |
1 |
0.0008 |
| 280 |
ABDOMINAL OPERATION |
1 |
0.0008 |
| 281 |
LOW BIRTH WEIGHT BABY |
6 |
0.0008 |
| 282 |
MATERNAL EXPOSURE DURING PREGNANCY |
67 |
0.0008 |
| 283 |
DEVICE DEFECTIVE |
13 |
0.0007 |
| 284 |
PRODUCT DELIVERY MECHANISM ISSUE |
4 |
0.0007 |
| 285 |
URETERIC OBSTRUCTION |
1 |
0.0007 |
| 286 |
DEMYELINATION |
3 |
0.0007 |
| 287 |
PERITONEAL HAEMORRHAGE |
1 |
0.0007 |
| 288 |
DEATH NEONATAL |
1 |
0.0007 |
| 289 |
LIVE BIRTH |
6 |
0.0007 |
| 290 |
PERIPHERAL ARTERY THROMBOSIS |
1 |
0.0007 |
| 291 |
ANTICONVULSANT DRUG LEVEL DECREASED |
1 |
0.0007 |
| 292 |
PREMATURE LABOUR |
4 |
0.0007 |
| 293 |
INTENSIVE CARE |
1 |
0.0007 |
| 294 |
INJECTION SITE HYPOAESTHESIA |
1 |
0.0007 |
| 295 |
HAEMORRHAGE IN PREGNANCY |
1 |
0.0007 |
| 296 |
PORPHYRIA ACUTE |
1 |
0.0007 |
| 297 |
RETINAL VEIN OCCLUSION |
2 |
0.0007 |
| 298 |
DYSPNOEA AT REST |
2 |
0.0007 |
| 299 |
HYPOTHALAMO-PITUITARY DISORDER |
1 |
0.0007 |
| 300 |
ABORTION |
2 |
0.0007 |
| 301 |
PREGNANCY ON CONTRACEPTIVE |
1 |
0.0007 |
| 302 |
PULMONARY PAIN |
2 |
0.0007 |
| 303 |
MELANOCYTIC NAEVUS |
3 |
0.0007 |
| 304 |
UTERINE LEIOMYOMA |
5 |
0.0007 |
| 305 |
NEPHRECTOMY |
1 |
0.0007 |
| 306 |
ILEUS PARALYTIC |
3 |
0.0007 |
| 307 |
PELVIC INFLAMMATORY DISEASE |
1 |
0.0007 |
| 308 |
HAEMORRHAGIC TRANSFORMATION STROKE |
1 |
0.0007 |
| 309 |
ADHESION |
1 |
0.0007 |
| 310 |
MATERNAL DRUGS AFFECTING FOETUS |
5 |
0.0007 |
| 311 |
PREMATURE SEPARATION OF PLACENTA |
1 |
0.0006 |
| 312 |
INFERTILITY FEMALE |
1 |
0.0006 |
| 313 |
BACTERIAL VAGINOSIS |
1 |
0.0006 |
| 314 |
INJECTION SITE HYPERSENSITIVITY |
2 |
0.0006 |
| 315 |
TRANSCRIPTION MEDICATION ERROR |
1 |
0.0006 |
| 316 |
INCORRECT DOSE ADMINISTERED BY PRODUCT |
1 |
0.0006 |
| 317 |
FOCAL SEGMENTAL GLOMERULOSCLEROSIS |
1 |
0.0006 |
| 318 |
STILLBIRTH |
3 |
0.0006 |
| 319 |
DEVICE MALFUNCTION |
43 |
0.0006 |
| 320 |
EXPIRED DEVICE USED |
2 |
0.0006 |
| 321 |
GASTRIC DILATATION |
1 |
0.0006 |
| 322 |
OLIGOHYDRAMNIOS |
2 |
0.0006 |
| 323 |
DEVICE LEAKAGE |
26 |
0.0006 |
| 324 |
TONSILLECTOMY |
1 |
0.0006 |
| 325 |
SALMONELLOSIS |
1 |
0.0006 |
| 326 |
SLEEP TALKING |
1 |
0.0006 |
| 327 |
WEIGHT LOSS POOR |
3 |
0.0006 |
| 328 |
SUDDEN CARDIAC DEATH |
2 |
0.0006 |
| 329 |
CEREBRAL ISCHAEMIA |
3 |
0.0006 |
| 330 |
BLOOD CHLORIDE INCREASED |
1 |
0.0006 |
| 331 |
LACK OF INJECTION SITE ROTATION |
1 |
0.0006 |
| 332 |
PRODUCT TAMPERING |
1 |
0.0006 |
| 333 |
INJECTION SITE IRRITATION |
7 |
0.0005 |
| 334 |
RETINOPATHY |
2 |
0.0005 |
| 335 |
MATERNAL EXPOSURE TIMING UNSPECIFIED |
2 |
0.0005 |
| 336 |
BREAST TENDERNESS |
4 |
0.0005 |
| 337 |
JAUNDICE NEONATAL |
1 |
0.0005 |
| 338 |
PRODUCT STORAGE ISSUE |
2 |
0.0005 |
| 339 |
PRODUCT QUALITY ISSUE |
71 |
0.0005 |
| 340 |
VENOUS THROMBOSIS |
2 |
0.0005 |
| 341 |
AFFECTIVE DISORDER |
4 |
0.0005 |
| 342 |
REVERSIBLE CEREBRAL VASOCONSTRICTION SYNDROME |
1 |
0.0005 |
| 343 |
DIPLEGIA |
1 |
0.0005 |
| 344 |
EXPOSURE VIA BREAST MILK |
2 |
0.0005 |
| 345 |
ANORECTAL DISORDER |
1 |
0.0005 |
| 346 |
MUCOSAL DRYNESS |
1 |
0.0005 |
| 347 |
SUDDEN HEARING LOSS |
1 |
0.0005 |
| 348 |
INJECTION SITE REACTION |
34 |
0.0005 |
| 349 |
INJURY ASSOCIATED WITH DEVICE |
10 |
0.0005 |
| 350 |
GOITRE |
2 |
0.0005 |
| 351 |
ABNORMAL FAECES |
4 |
0.0005 |
| 352 |
POLYCYTHAEMIA |
1 |
0.0005 |
| 353 |
CAPILLARY LEAK SYNDROME |
1 |
0.0005 |
| 354 |
MENSTRUAL DISORDER |
4 |
0.0005 |
| 355 |
DEVICE MATERIAL ISSUE |
1 |
0.0005 |
| 356 |
OPTIC NEUROPATHY |
1 |
0.0005 |
| 357 |
EAR SWELLING |
1 |
0.0005 |
| 358 |
HEPATIC CYTOLYSIS |
6 |
0.0005 |
| 359 |
BREAST PAIN |
5 |
0.0005 |
| 360 |
ANAEMIA MACROCYTIC |
1 |
0.0005 |
| 361 |
PRODUCT DISPENSING ISSUE |
2 |
0.0005 |
| 362 |
VAGINAL HAEMORRHAGE |
20 |
0.0005 |
| 363 |
CHAPPED LIPS |
2 |
0.0005 |
| 364 |
CERVICAL DYSPLASIA |
1 |
0.0005 |
| 365 |
VULVOVAGINAL DISCOMFORT |
2 |
0.0005 |
| 366 |
PRODUCT LOT NUMBER ISSUE |
1 |
0.0005 |
| 367 |
PREGNANCY |
9 |
0.0004 |
| 368 |
CORNEAL OEDEMA |
1 |
0.0004 |
| 369 |
IDIOPATHIC INTRACRANIAL HYPERTENSION |
1 |
0.0004 |
| 370 |
HAEMOGLOBIN INCREASED |
2 |
0.0004 |
| 371 |
NEPHROTIC SYNDROME |
3 |
0.0004 |
| 372 |
REACTION TO EXCIPIENT |
1 |
0.0004 |
| 373 |
HYPERTRANSAMINASAEMIA |
3 |
0.0004 |
| 374 |
INJECTION SITE RASH |
13 |
0.0004 |
| 375 |
METASTASIS |
3 |
0.0004 |
| 376 |
URINARY HESITATION |
1 |
0.0004 |
| 377 |
INJECTION SITE PRURITUS |
28 |
0.0004 |
| 378 |
PULSE ABNORMAL |
1 |
0.0004 |
| 379 |
DRUG EXPOSURE DURING PREGNANCY |
14 |
0.0004 |
| 380 |
LIQUID PRODUCT PHYSICAL ISSUE |
3 |
0.0004 |
| 381 |
CIRCULATORY COLLAPSE |
7 |
0.0004 |
| 382 |
HORMONE LEVEL ABNORMAL |
2 |
0.0004 |
| 383 |
GLOMERULONEPHRITIS |
1 |
0.0004 |
| 384 |
EYE OEDEMA |
1 |
0.0004 |
| 385 |
EXPIRED DRUG ADMINISTERED |
2 |
0.0004 |
| 386 |
INJECTION SITE ABSCESS |
1 |
0.0004 |
| 387 |
VENTRICULAR HYPERTROPHY |
1 |
0.0004 |
| 388 |
VAGINAL DISCHARGE |
4 |
0.0004 |
| 389 |
APPENDICITIS PERFORATED |
1 |
0.0004 |
| 390 |
LACTOSE INTOLERANCE |
1 |
0.0004 |
| 391 |
MUSCULOSKELETAL CHEST PAIN |
6 |
0.0004 |
| 392 |
FOETAL DEATH |
2 |
0.0004 |
| 393 |
HOT FLUSH |
29 |
0.0004 |
| 394 |
POSTMENOPAUSAL HAEMORRHAGE |
1 |
0.0004 |
| 395 |
COMPARTMENT SYNDROME |
1 |
0.0004 |
| 396 |
PRODUCT INEFFECTIVE FOR UNAPPROVED USE |
1 |
0.0004 |
| 397 |
SKIN DISCOMFORT |
1 |
0.0004 |
| 398 |
EXPOSURE DURING PREGNANCY |
23 |
0.0004 |
| 399 |
EAR CONGESTION |
1 |
0.0004 |
| 400 |
LIP BLISTER |
1 |
0.0004 |
| 401 |
HYDROCEPHALUS |
2 |
0.0004 |
| 402 |
INJECTION SITE BRUISING |
29 |
0.0004 |
| 403 |
THYROID NEOPLASM |
1 |
0.0004 |
| 404 |
PLEURITIC PAIN |
1 |
0.0004 |
| 405 |
INTERMENSTRUAL BLEEDING |
2 |
0.0004 |
| 406 |
OESOPHAGEAL STENOSIS |
1 |
0.0004 |
| 407 |
INJECTION SITE SCAR |
1 |
0.0004 |
| 408 |
COMA SCALE ABNORMAL |
1 |
0.0003 |
| 409 |
MOOD SWINGS |
11 |
0.0003 |
| 410 |
DEVICE BREAKAGE |
14 |
0.0003 |
| 411 |
HAEMOTHORAX |
1 |
0.0003 |
| 412 |
URINE OUTPUT DECREASED |
3 |
0.0003 |
| 413 |
AUTONOMIC NERVOUS SYSTEM IMBALANCE |
1 |
0.0003 |
| 414 |
HYPOVOLAEMIA |
2 |
0.0003 |
| 415 |
STRABISMUS |
1 |
0.0003 |
| 416 |
ABDOMINAL PAIN |
79 |
0.0003 |
| 417 |
EMERGENCY CARE |
1 |
0.0003 |
| 418 |
KERATITIS |
1 |
0.0003 |
| 419 |
INCORRECT DOSE ADMINISTERED |
75 |
0.0003 |
| 420 |
DYSCHEZIA |
1 |
0.0003 |
| 421 |
INJECTION SITE MASS |
12 |
0.0003 |
| 422 |
THYROID DISORDER |
5 |
0.0003 |
| 423 |
CYST |
4 |
0.0003 |
| 424 |
APPENDICITIS |
3 |
0.0003 |
| 425 |
BLOOD CREATININE DECREASED |
1 |
0.0003 |
| 426 |
ABORTION INDUCED |
3 |
0.0003 |
| 427 |
DERMATITIS ALLERGIC |
4 |
0.0003 |
| 428 |
NON-CARDIAC CHEST PAIN |
1 |
0.0003 |
| 429 |
CARDIOVASCULAR DISORDER |
8 |
0.0003 |
| 430 |
PREMATURE DELIVERY |
5 |
0.0003 |
| 431 |
OCCUPATIONAL EXPOSURE TO PRODUCT |
2 |
0.0003 |
| 432 |
LOOSE TOOTH |
1 |
0.0003 |
| 433 |
HEPATITIS ACUTE |
2 |
0.0003 |
| 434 |
POLYP |
2 |
0.0003 |
| 435 |
BREAST ENLARGEMENT |
1 |
0.0003 |
| 436 |
INJECTION SITE INFECTION |
1 |
0.0003 |
| 437 |
PREMATURE BABY |
9 |
0.0003 |
| 438 |
WRONG PRODUCT ADMINISTERED |
2 |
0.0003 |
| 439 |
PRODUCT LABEL ISSUE |
2 |
0.0003 |
| 440 |
HEPATIC CYST |
1 |
0.0003 |
| 441 |
EAR DISCOMFORT |
3 |
0.0003 |
| 442 |
INCORRECT ROUTE OF PRODUCT ADMINISTRATION |
5 |
0.0003 |
| 443 |
PRIAPISM |
1 |
0.0003 |
| 444 |
HAIR GROWTH ABNORMAL |
2 |
0.0003 |
| 445 |
INJECTION SITE URTICARIA |
7 |
0.0003 |
| 446 |
INJECTION SITE DISCOMFORT |
3 |
0.0003 |
| 447 |
COLD SWEAT |
5 |
0.0003 |
| 448 |
NEONATAL RESPIRATORY DISTRESS SYNDROME |
1 |
0.0003 |
| 449 |
FIBRIN D DIMER INCREASED |
1 |
0.0003 |
| 450 |
PRODUCT CONTAMINATION |
1 |
0.0003 |
| 451 |
PRODUCT SUPPLY ISSUE |
2 |
0.0003 |
| 452 |
WRONG TECHNIQUE IN DEVICE USAGE PROCESS |
13 |
0.0003 |
| 453 |
THROMBOCYTOSIS |
1 |
0.0003 |
| 454 |
BLINDNESS TRANSIENT |
2 |
0.0003 |
| 455 |
PANCREATITIS ACUTE |
6 |
0.0003 |
| 456 |
PROTEIN TOTAL DECREASED |
1 |
0.0003 |
| 457 |
DYSPNOEA EXERTIONAL |
10 |
0.0003 |
| 458 |
AUTOIMMUNE THYROIDITIS |
1 |
0.0003 |
| 459 |
SNORING |
1 |
0.0003 |
| 460 |
FACE INJURY |
1 |
0.0003 |
| 461 |
PRODUCT STORAGE ERROR |
23 |
0.0003 |
| 462 |
CONGENITAL ANOMALY |
2 |
0.0003 |
| 463 |
PANIC DISORDER |
1 |
0.0003 |
| 464 |
RHINOVIRUS INFECTION |
1 |
0.0003 |
| 465 |
PRODUCT ADMINISTRATION INTERRUPTED |
2 |
0.0003 |
| 466 |
SUSPECTED COUNTERFEIT PRODUCT |
1 |
0.0003 |
| 467 |
PATENT DUCTUS ARTERIOSUS |
1 |
0.0003 |
| 468 |
CHOLECYSTITIS |
3 |
0.0003 |
| 469 |
BLEPHARITIS |
1 |
0.0002 |
| 470 |
MUSCLE HAEMORRHAGE |
1 |
0.0002 |
| 471 |
MATERNAL EXPOSURE DURING BREAST FEEDING |
1 |
0.0002 |
| 472 |
FOETAL EXPOSURE DURING PREGNANCY |
20 |
0.0002 |
| 473 |
ARTHRITIS BACTERIAL |
1 |
0.0002 |
| 474 |
INJECTION SITE ERYTHEMA |
30 |
0.0002 |
| 475 |
PERITONITIS |
5 |
0.0002 |
| 476 |
THYROID FUNCTION TEST ABNORMAL |
1 |
0.0002 |
| 477 |
INJECTION SITE DISCOLOURATION |
3 |
0.0002 |
| 478 |
ATRIAL SEPTAL DEFECT |
2 |
0.0002 |
| 479 |
ATTENTION DEFICIT HYPERACTIVITY DISORDER |
1 |
0.0002 |
| 480 |
INCORRECT DRUG ADMINISTRATION RATE |
1 |
0.0002 |
| 481 |
POOR PERIPHERAL CIRCULATION |
1 |
0.0002 |
| 482 |
UTERINE HAEMORRHAGE |
1 |
0.0002 |
| 483 |
METRORRHAGIA |
4 |
0.0002 |
| 484 |
LEFT VENTRICULAR HYPERTROPHY |
1 |
0.0002 |
| 485 |
PRODUCT CONTAINER ISSUE |
2 |
0.0002 |
| 486 |
DEVICE OPERATIONAL ISSUE |
1 |
0.0002 |
| 487 |
PRODUCT DOSE OMISSION |
15 |
0.0002 |
| 488 |
PRODUCT PRESCRIBING ISSUE |
5 |
0.0002 |
| 489 |
HYPERKALAEMIA |
8 |
0.0002 |
| 490 |
EMOTIONAL DISORDER |
7 |
0.0002 |
| 491 |
ADVERSE REACTION |
3 |
0.0002 |
| 492 |
HEADACHE |
140 |
0.0002 |
| 493 |
HAEMOLYTIC ANAEMIA |
2 |
0.0002 |
| 494 |
BLOOD BILIRUBIN INCREASED |
6 |
0.0002 |
| 495 |
OROPHARYNGEAL DISCOMFORT |
2 |
0.0002 |
| 496 |
SUSPECTED OFF LABEL USE |
1 |
0.0002 |
| 497 |
LIP DRY |
2 |
0.0002 |
| 498 |
MOOD ALTERED |
6 |
0.0002 |
| 499 |
PRODUCT AVAILABILITY ISSUE |
5 |
0.0002 |
| 500 |
INJECTION SITE PAPULE |
1 |
0.0002 |
| 501 |
INJECTION SITE PAIN |
67 |
0.0002 |
| 502 |
IMMUNE THROMBOCYTOPENIA |
1 |
0.0002 |
| 503 |
CENTRAL NERVOUS SYSTEM LESION |
3 |
0.0002 |
| 504 |
DYSPAREUNIA |
1 |
0.0002 |
| 505 |
SKIN TIGHTNESS |
1 |
0.0002 |
| 506 |
BLOOD PROLACTIN INCREASED |
1 |
0.0002 |
| 507 |
SARCOIDOSIS |
1 |
0.0002 |
| 508 |
PRE-ECLAMPSIA |
1 |
0.0002 |
| 509 |
PULSE ABSENT |
1 |
0.0002 |
| 510 |
GESTATIONAL DIABETES |
1 |
0.0002 |
| 511 |
ATELECTASIS |
2 |
0.0002 |
| 512 |
GUILLAIN-BARRE SYNDROME |
1 |
0.0002 |
| 513 |
INCORRECT DOSAGE ADMINISTERED |
1 |
0.0002 |
| 514 |
PHARYNGEAL SWELLING |
2 |
0.0002 |
| 515 |
APPLICATION SITE SWELLING |
1 |
0.0002 |
| 516 |
SYNCOPE |
20 |
0.0002 |
| 517 |
OSTEOPENIA |
3 |
0.0002 |
| 518 |
DRUG DELIVERY SYSTEM MALFUNCTION |
1 |
0.0002 |
| 519 |
PHLEBITIS |
1 |
0.0002 |
| 520 |
HYPONATRAEMIA |
11 |
0.0002 |
| 521 |
INCREASED UPPER AIRWAY SECRETION |
1 |
0.0002 |
| 522 |
CACHEXIA |
1 |
0.0002 |
| 523 |
STOMACH DISCOMFORT |
1 |
0.0002 |
| 524 |
EXPOSURE VIA SKIN CONTACT |
5 |
0.0002 |
| 525 |
FAILURE TO THRIVE |
1 |
0.0002 |
| 526 |
VENTRICULAR EXTRASYSTOLES |
2 |
0.0002 |
| 527 |
PETECHIAE |
2 |
0.0002 |
| 528 |
CATATONIA |
1 |
0.0002 |
| 529 |
PRODUCT DOSE OMISSION ISSUE |
56 |
0.0002 |
| 530 |
INTESTINAL RESECTION |
1 |
0.0002 |
| 531 |
CHEILITIS |
1 |
0.0002 |
| 532 |
PALLOR |
5 |
0.0002 |
| 533 |
INFECTIVE PULMONARY EXACERBATION OF CYSTIC FIBROSIS |
1 |
0.0002 |
| 534 |
PRODUCT DISPENSING ERROR |
4 |
0.0002 |
| 535 |
GASTROINTESTINAL PAIN |
2 |
0.0002 |
| 536 |
AUTISM SPECTRUM DISORDER |
1 |
0.0002 |
| 537 |
DEAFNESS UNILATERAL |
1 |
0.0002 |
| 538 |
DEVICE DIFFICULT TO USE |
12 |
0.0002 |
| 539 |
CYSTIC FIBROSIS |
1 |
0.0002 |
| 540 |
INJECTION SITE INJURY |
1 |
0.0002 |
| 541 |
NECROSIS |
1 |
0.0002 |
| 542 |
INTRACRANIAL PRESSURE INCREASED |
1 |
0.0002 |
| 543 |
MACULAR OEDEMA |
1 |
0.0002 |
| 544 |
POST PROCEDURAL HAEMORRHAGE |
2 |
0.0002 |
| 545 |
INJECTION SITE SWELLING |
13 |
0.0002 |
| 546 |
THIRST |
3 |
0.0002 |
| 547 |
PROTHROMBIN TIME PROLONGED |
1 |
0.0002 |
| 548 |
TYPE 1 DIABETES MELLITUS |
1 |
0.0002 |
| 549 |
CHEST DISCOMFORT |
17 |
0.0002 |
| 550 |
LEUKOCYTOSIS |
3 |
0.0002 |
| 551 |
INJECTION SITE VESICLES |
1 |
0.0002 |
| 552 |
INGUINAL HERNIA |
1 |
0.0002 |
| 553 |
LIVER INJURY |
4 |
0.0002 |
| 554 |
GENERALISED OEDEMA |
2 |
0.0002 |
| 555 |
PRODUCT USE IN UNAPPROVED INDICATION |
40 |
0.0002 |
| 556 |
BLEPHAROSPASM |
1 |
0.0002 |
| 557 |
THERAPEUTIC RESPONSE CHANGED |
1 |
0.0002 |
| 558 |
DRUG INTERACTION |
25 |
0.0002 |
| 559 |
HYPOTHYROIDISM |
5 |
0.0002 |
| 560 |
CHOLESTASIS |
3 |
0.0002 |
| 561 |
DEVICE ISSUE |
14 |
0.0002 |
| 562 |
CONTUSION |
15 |
0.0002 |
| 563 |
POOR QUALITY DRUG ADMINISTERED |
1 |
0.0002 |
| 564 |
HYPERPROLACTINAEMIA |
1 |
0.0002 |
| 565 |
SLEEP DISORDER DUE TO GENERAL MEDICAL CONDITION, INSOMNIA TYPE |
1 |
0.0002 |
| 566 |
BRADYPHRENIA |
1 |
0.0002 |
| 567 |
PRODUCT PREPARATION ISSUE |
1 |
0.0002 |
| 568 |
HAEMATOCRIT DECREASED |
3 |
0.0002 |
| 569 |
DYSMENORRHOEA |
2 |
0.0002 |
| 570 |
ASPARTATE AMINOTRANSFERASE INCREASED |
8 |
0.0002 |
| 571 |
LIP SWELLING |
5 |
0.0001 |
| 572 |
PRODUCT ADMINISTRATION ERROR |
3 |
0.0001 |
| 573 |
TACHYPNOEA |
2 |
0.0001 |
| 574 |
MIGRAINE |
14 |
0.0001 |
| 575 |
NAUSEA |
115 |
0.0001 |
| 576 |
RESPIRATORY DISTRESS |
4 |
0.0001 |
| 577 |
ABNORMAL DREAMS |
4 |
0.0001 |
| 578 |
PROCEDURAL PAIN |
4 |
0.0001 |
| 579 |
ABDOMINAL DISCOMFORT |
24 |
0.0001 |
| 580 |
PRODUCT DOSE OMISSION IN ERROR |
4 |
0.0001 |
| 581 |
THERMAL BURN |
1 |
0.0001 |
| 582 |
FEAR OF INJECTION |
1 |
0.0001 |
| 583 |
POOR QUALITY SLEEP |
3 |
0.0001 |
| 584 |
CEREBRAL DISORDER |
1 |
0.0001 |
| 585 |
HYDRONEPHROSIS |
1 |
0.0001 |
| 586 |
HYPOAESTHESIA ORAL |
2 |
0.0001 |
| 587 |
PEMPHIGOID |
1 |
0.0001 |
| 588 |
APPLICATION SITE PRURITUS |
3 |
0.0001 |
| 589 |
HYPERTHERMIA |
1 |
0.0001 |
| 590 |
MUSCLE SPASMS |
24 |
0.0001 |
| 591 |
DEVICE PHYSICAL PROPERTY ISSUE |
1 |
0.0001 |
| 592 |
LIPASE INCREASED |
1 |
0.0001 |
| 593 |
ALANINE AMINOTRANSFERASE INCREASED |
8 |
0.0001 |
| 594 |
HYPOALBUMINAEMIA |
1 |
0.0001 |
| 595 |
APNOEA |
1 |
0.0001 |
| 596 |
HAEMORRHAGIC STROKE |
1 |
0.0001 |
| 597 |
ARTERIAL OCCLUSIVE DISEASE |
1 |
0.0001 |
| 598 |
BLOOD ALBUMIN DECREASED |
1 |
0.0001 |
| 599 |
RENAL CYST |
1 |
0.0001 |
| 600 |
RASH ERYTHEMATOUS |
6 |
0.0001 |
| 601 |
BLOOD DISORDER |
1 |
0.0001 |
| 602 |
CONSTIPATION |
27 |
0.0001 |
| 603 |
MUSCLE DISORDER |
1 |
0.0001 |
| 604 |
BLOOD POTASSIUM INCREASED |
2 |
0.0001 |
| 605 |
POLYURIA |
1 |
0.0001 |
| 606 |
ESCHERICHIA INFECTION |
1 |
0.0001 |
| 607 |
MANIA |
2 |
0.0001 |
| 608 |
ACUTE CORONARY SYNDROME |
1 |
0.0001 |
| 609 |
EMBOLISM |
1 |
0.0001 |
| 610 |
BREAST CANCER STAGE II |
1 |
0.0001 |
| 611 |
COAGULOPATHY |
2 |
0.0001 |
| 612 |
PALPITATIONS |
14 |
0.0001 |
| 613 |
URTICARIA |
20 |
0.0001 |
| 614 |
ADVERSE EVENT |
11 |
0.0001 |
| 615 |
HAEMATURIA |
4 |
0.0001 |
| 616 |
DRUG REACTION WITH EOSINOPHILIA AND SYSTEMIC SYMPTOMS |
3 |
0.0001 |
| 617 |
DIPLOPIA |
3 |
0.0001 |
| 618 |
ORTHOSTATIC HYPOTENSION |
2 |
0.0001 |
| 619 |
DEVICE USE ISSUE |
2 |
0.0001 |
| 620 |
NAIL DISORDER |
1 |
0.0001 |
| 621 |
SYRINGE ISSUE |
2 |
0.0001 |
| 622 |
BURNING SENSATION |
8 |
0.0001 |
| 623 |
AMENORRHOEA |
2 |
0.0001 |
| 624 |
BLOOD CALCIUM INCREASED |
1 |
0.0001 |
| 625 |
PRODUCT COMMUNICATION ISSUE |
1 |
0.0001 |
| 626 |
WEIGHT INCREASED |
25 |
0.0001 |
| 627 |
HAEMARTHROSIS |
1 |
0.0001 |
| 628 |
FEAR |
3 |
0.0001 |
| 629 |
VOMITING |
52 |
0.0001 |
| 630 |
CRYING |
4 |
0.0001 |
| 631 |
HIDRADENITIS |
1 |
0.0001 |
| 632 |
PRODUCT ADMINISTERED AT INAPPROPRIATE SITE |
2 |
0.0001 |
| 633 |
BLOOD THYROID STIMULATING HORMONE INCREASED |
1 |
0.0001 |
| 634 |
OVARIAN CANCER |
1 |
0.0001 |
| 635 |
PERSONALITY CHANGE |
1 |
0.0001 |
| 636 |
ERYTHEMA MULTIFORME |
1 |
0.0001 |
| 637 |
DYSPNOEA |
60 |
0.0001 |
| 638 |
LEUKAEMIA |
1 |
0.0001 |
| 639 |
INTENTIONAL DOSE OMISSION |
3 |
0.0001 |
| 640 |
POSTERIOR REVERSIBLE ENCEPHALOPATHY SYNDROME |
1 |
0.0001 |
| 641 |
WHITE BLOOD CELL COUNT INCREASED |
4 |
0.0001 |
| 642 |
DIZZINESS |
52 |
0.0001 |
| 643 |
FATIGUE |
81 |
0.0001 |
| 644 |
HEPATIC ENZYME INCREASED |
7 |
0.0001 |
| 645 |
THROMBOTIC MICROANGIOPATHY |
1 |
0.0001 |
| 646 |
MENORRHAGIA |
2 |
0.0001 |
| 647 |
CONTRAINDICATED PRODUCT ADMINISTERED |
3 |
0.0001 |
| 648 |
SUBARACHNOID HAEMORRHAGE |
1 |
0.0001 |
| 649 |
NEUTROPHIL COUNT INCREASED |
1 |
0.0001 |
| 650 |
INJECTION SITE WARMTH |
2 |
0.0001 |
| 651 |
ACCIDENTAL EXPOSURE TO PRODUCT |
10 |
0.0001 |
| 652 |
LIMB DISCOMFORT |
3 |
0.0001 |
| 653 |
DRUG DOSE OMISSION |
16 |
0.0001 |
| 654 |
TENDERNESS |
1 |
0.0001 |
| 655 |
POLLAKIURIA |
4 |
0.0001 |
| 656 |
UNDERDOSE |
7 |
0.0001 |
| 657 |
TRANSFUSION |
1 |
0.0001 |
| 658 |
SUDDEN DEATH |
1 |
0.0001 |
| 659 |
RENAL PAIN |
1 |
0.0001 |
| 660 |
RETCHING |
2 |
0.0001 |
| 661 |
HEREDITARY ANGIOEDEMA |
1 |
0.0001 |
| 662 |
DECREASED ACTIVITY |
1 |
0.0001 |
| 663 |
PRURITUS GENERALISED |
2 |
0.0001 |
| 664 |
DEEP VEIN THROMBOSIS |
6 |
0.0001 |
| 665 |
MENSTRUATION DELAYED |
1 |
0.0001 |
| 666 |
BACK INJURY |
1 |
0.0001 |
| 667 |
PULMONARY THROMBOSIS |
1 |
0.0001 |
| 668 |
OESOPHAGITIS |
1 |
0.0001 |
| 669 |
CHOLELITHIASIS |
3 |
0.0001 |
| 670 |
PRURITUS |
35 |
0.0001 |
| 671 |
GAMMA-GLUTAMYLTRANSFERASE INCREASED |
2 |
0.0001 |
| 672 |
TRANSAMINASES INCREASED |
2 |
0.0001 |
| 673 |
URINARY RETENTION |
3 |
0.0001 |
| 674 |
GAIT INABILITY |
3 |
0.0001 |
| 675 |
COLITIS ULCERATIVE |
4 |
0.0001 |
| 676 |
MALNUTRITION |
1 |
0.0001 |
| 677 |
NEPHROPATHY TOXIC |
1 |
0.0001 |
| 678 |
FLATULENCE |
5 |
0.0001 |
| 679 |
SCAB |
1 |
0.0001 |
| 680 |
RASH |
38 |
0.0001 |
| 681 |
METASTASES TO LUNG |
1 |
0.0001 |
| 682 |
PERICARDIAL EFFUSION |
2 |
0.0001 |
| 683 |
ELECTROLYTE IMBALANCE |
1 |
0.0001 |
| 684 |
EYELID OEDEMA |
1 |
0.0001 |
| 685 |
SWELLING |
8 |
0.0001 |
| 686 |
SPLENOMEGALY |
1 |
0.0001 |
| 687 |
BLOOD IRON DECREASED |
1 |
0.0001 |
| 688 |
IRRITABILITY |
5 |
0.0001 |
| 689 |
ABDOMINAL PAIN UPPER |
17 |
0.0001 |
| 690 |
C-REACTIVE PROTEIN INCREASED |
3 |
0.0001 |
| 691 |
PRESYNCOPE |
2 |
0.0001 |
| 692 |
VERTIGO |
5 |
0.0001 |
| 693 |
ACCIDENTAL OVERDOSE |
3 |
0.0001 |
| 694 |
DYSURIA |
3 |
0.0001 |
| 695 |
OFF LABEL USE |
71 |
0.0001 |
| 696 |
BLOOD ALKALINE PHOSPHATASE INCREASED |
2 |
0.0001 |
| 697 |
HEPATIC FUNCTION ABNORMAL |
3 |
0.0001 |
| 698 |
TOOTH EXTRACTION |
1 |
0.0001 |
| 699 |
BRAIN OEDEMA |
1 |
0.0001 |
| 700 |
DEVICE DEPLOYMENT ISSUE |
1 |
0.0001 |
| 701 |
INTRAOCULAR PRESSURE INCREASED |
1 |
0.0001 |
| 702 |
HYPOPHAGIA |
2 |
0.0001 |
| 703 |
PERIPHERAL SWELLING |
12 |
0.0001 |
| 704 |
HIATUS HERNIA |
1 |
0.0001 |
| 705 |
PLATELET COUNT INCREASED |
1 |
0.0001 |
| 706 |
NODULE |
1 |
0.0001 |
| 707 |
SUICIDAL IDEATION |
7 |
0.0001 |
| 708 |
APPLICATION SITE ERYTHEMA |
2 |
0.0001 |
| 709 |
INCORRECT PRODUCT STORAGE |
1 |
0.0001 |
| 710 |
GASTRITIS |
2 |
0.0001 |
| 711 |
ANKYLOSING SPONDYLITIS |
1 |
0.0001 |
| 712 |
PULMONARY CONGESTION |
1 |
0.0001 |
| 713 |
PANCREATITIS |
4 |
0.0001 |
| 714 |
CONDITION AGGRAVATED |
23 |
0.0001 |
| 715 |
QUALITY OF LIFE DECREASED |
1 |
0.0001 |
| 716 |
SINUS CONGESTION |
1 |
0.0001 |
| 717 |
THROAT TIGHTNESS |
2 |
0.0001 |
| 718 |
OEDEMA |
4 |
0.0001 |
| 719 |
PULMONARY EMBOLISM |
7 |
0.0001 |
| 720 |
LIMB INJURY |
2 |
0.0001 |
| 721 |
GINGIVAL BLEEDING |
1 |
0.0001 |
| 722 |
PERIPHERAL COLDNESS |
1 |
0.0001 |
| 723 |
HUNGER |
1 |
0.0001 |
| 724 |
CARDIO-RESPIRATORY ARREST |
3 |
0.0001 |
| 725 |
PAIN |
44 |
0.0001 |
| 726 |
DYSPEPSIA |
7 |
0.0001 |
| 727 |
DISSEMINATED INTRAVASCULAR COAGULATION |
1 |
0.0001 |
| 728 |
BLINDNESS UNILATERAL |
1 |
0.0001 |
| 729 |
RENAL FAILURE ACUTE |
3 |
0.0001 |
| 730 |
PARAESTHESIA ORAL |
1 |
0.0001 |
| 731 |
HYPOKINESIA |
1 |
0.0001 |
| 732 |
INTENTIONAL PRODUCT MISUSE |
6 |
0.0001 |
| 733 |
PSYCHOTIC DISORDER |
2 |
0.0001 |
| 734 |
TACHYCARDIA |
6 |
0.0001 |
| 735 |
DRUG EFFECT LESS THAN EXPECTED |
1 |
0.0001 |
| 736 |
HAEMORRHAGE INTRACRANIAL |
1 |
0.0001 |
| 737 |
APHASIA |
2 |
0.0001 |
| 738 |
DISCOMFORT |
4 |
0.0001 |
| 739 |
DRUG DISPENSING ERROR |
1 |
0.0001 |
| 740 |
NEPHROLITHIASIS |
3 |
0.0001 |
| 741 |
PHARYNGEAL OEDEMA |
1 |
0.0001 |
| 742 |
HYPOKALAEMIA |
3 |
0.0001 |
| 743 |
COGNITIVE DISORDER |
3 |
0.0001 |
| 744 |
MENINGIOMA |
1 |
0.0001 |
| 745 |
SWOLLEN TONGUE |
2 |
0.0001 |
| 746 |
BRAIN FOG |
1 |
0.0001 |
| 747 |
PRODUCT USE COMPLAINT |
1 |
0.0001 |
| 748 |
BLOOD LACTATE DEHYDROGENASE INCREASED |
1 |
0.0001 |
| 749 |
PNEUMOTHORAX |
1 |
0.0001 |
| 750 |
THROMBOSIS |
5 |
0.0001 |
| 751 |
NIGHT SWEATS |
2 |
0.0001 |
| 752 |
MUSCLE TIGHTNESS |
1 |
0.0001 |
| 753 |
METASTASES TO BONE |
1 |
0.0001 |
| 754 |
STAPHYLOCOCCAL INFECTION |
2 |
0.0001 |
| 755 |
SEIZURE |
7 |
0.0001 |
| 756 |
FUNGAL INFECTION |
2 |
0.0001 |
| 757 |
SKIN DISORDER |
2 |
0.0001 |
| 758 |
BLOOD UREA INCREASED |
1 |
0.0001 |
| 759 |
CHILLS |
7 |
0.0001 |
| 760 |
SOMNOLENCE |
12 |
0.0001 |
| 761 |
HYPERSENSITIVITY |
11 |
0.0001 |
| 762 |
ANGER |
2 |
0.0001 |
| 763 |
HEMIPARESIS |
1 |
0.0001 |
| 764 |
SLEEP DISORDER DUE TO A GENERAL MEDICAL CONDITION |
1 |
0.0001 |
| 765 |
THERAPY CESSATION |
3 |
0.0001 |
| 766 |
SCAR |
1 |
0.0001 |
| 767 |
VISION BLURRED |
8 |
0.0001 |
| 768 |
INFLAMMATION |
3 |
0.0001 |
| 769 |
PARANOIA |
1 |
0.0001 |
| 770 |
SPEECH DISORDER |
3 |
0.0001 |
| 771 |
SLEEP DISORDER |
4 |
0.0001 |
| 772 |
ACUTE RESPIRATORY DISTRESS SYNDROME |
1 |
0.0001 |
| 773 |
SYSTEMIC LUPUS ERYTHEMATOSUS |
2 |
0.0001 |
| 774 |
THERAPY INTERRUPTED |
4 |
0.0001 |
| 775 |
GASTROENTERITIS VIRAL |
1 |
0.0001 |
| 776 |
RASH PRURITIC |
3 |
0.0001 |
| 777 |
COMPLICATION OF DEVICE REMOVAL |
1 |
0.0001 |
| 778 |
RESTLESS LEGS SYNDROME |
1 |
0.0001 |
| 779 |
BONE DISORDER |
1 |
0.0001 |
| 780 |
END STAGE RENAL DISEASE |
1 |
0.0001 |
| 781 |
ANAPHYLACTIC REACTION |
3 |
0.0001 |
| 782 |
HEPATIC STEATOSIS |
1 |
0.0001 |
| 783 |
BLOOD SODIUM DECREASED |
1 |
0.0001 |
| 784 |
PROTEINURIA |
1 |
0.0001 |
| 785 |
FEELING JITTERY |
1 |
0.0001 |
| 786 |
SLEEP APNOEA SYNDROME |
1 |
0.0001 |
| 787 |
INCREASED APPETITE |
1 |
0.0001 |
| 788 |
PULMONARY FIBROSIS |
1 |
0.0001 |
| 789 |
POST PROCEDURAL COMPLICATION |
1 |
0.0001 |
| 790 |
LOWER LIMB FRACTURE |
1 |
0.0001 |
| 791 |
PYREXIA |
18 |
0.0001 |
| 792 |
GLAUCOMA |
1 |
0.0001 |
| 793 |
PRESCRIBED OVERDOSE |
1 |
0.0001 |
| 794 |
DECREASED APPETITE |
12 |
0.0001 |
| 795 |
EAR PAIN |
1 |
0.0001 |
| 796 |
ORAL HERPES |
1 |
0.0001 |
| 797 |
BONE PAIN |
3 |
0.0001 |
| 798 |
SURGERY |
3 |
0.0001 |
| 799 |
DRUG DOSE OMISSION BY DEVICE |
4 |
0.0001 |
| 800 |
ASTHENIA |
19 |
0.0001 |
| 801 |
PRESCRIBED UNDERDOSE |
1 |
0.0001 |
| 802 |
INJECTION SITE HAEMORRHAGE |
4 |
0.0001 |
| 803 |
SUICIDE ATTEMPT |
3 |
0.0000 |
| 804 |
FLUSHING |
5 |
0.0000 |
| 805 |
BODY TEMPERATURE INCREASED |
1 |
0.0000 |
| 806 |
FEELING HOT |
3 |
0.0000 |
| 807 |
LUNG NEOPLASM MALIGNANT |
2 |
0.0000 |
| 808 |
CHEST PAIN |
9 |
0.0000 |
| 809 |
DERMATITIS |
1 |
0.0000 |
| 810 |
KNEE ARTHROPLASTY |
1 |
0.0000 |
| 811 |
HALLUCINATION, VISUAL |
1 |
0.0000 |
| 812 |
JOINT INJURY |
1 |
0.0000 |
| 813 |
IMPAIRED WORK ABILITY |
1 |
0.0000 |
| 814 |
DIARRHOEA |
30 |
0.0000 |
| 815 |
HYPOACUSIS |
2 |
0.0000 |
| 816 |
INCORRECT PRODUCT ADMINISTRATION DURATION |
1 |
0.0000 |
| 817 |
ALTERED STATE OF CONSCIOUSNESS |
1 |
0.0000 |
| 818 |
SWELLING FACE |
3 |
0.0000 |
| 819 |
FEELING ABNORMAL |
11 |
0.0000 |
| 820 |
STEVENS-JOHNSON SYNDROME |
1 |
0.0000 |
| 821 |
RASH MACULO-PAPULAR |
1 |
0.0000 |
| 822 |
RASH PAPULAR |
1 |
0.0000 |
| 823 |
SNEEZING |
1 |
0.0000 |
| 824 |
WRONG TECHNIQUE IN PRODUCT USAGE PROCESS |
9 |
0.0000 |
| 825 |
MUSCULAR WEAKNESS |
5 |
0.0000 |
| 826 |
SKIN IRRITATION |
2 |
0.0000 |
| 827 |
MUSCLE TWITCHING |
1 |
0.0000 |
| 828 |
PRODUCT USE ISSUE |
8 |
0.0000 |
| 829 |
ARRHYTHMIA |
2 |
0.0000 |
| 830 |
LOCALISED INFECTION |
1 |
0.0000 |
| 831 |
HYPOGLYCAEMIA |
2 |
0.0000 |
| 832 |
CEREBRAL INFARCTION |
1 |
0.0000 |
| 833 |
LUNG DISORDER |
2 |
0.0000 |
| 834 |
DYSGEUSIA |
3 |
0.0000 |
| 835 |
HEART RATE INCREASED |
4 |
0.0000 |
| 836 |
VISUAL IMPAIRMENT |
5 |
0.0000 |
| 837 |
HYPOAESTHESIA |
6 |
0.0000 |
| 838 |
COVID-19 |
7 |
0.0000 |
| 839 |
ACNE |
3 |
0.0000 |
| 840 |
PRODUCT COMPLAINT |
1 |
0.0000 |
| 841 |
HAEMATEMESIS |
1 |
0.0000 |
| 842 |
FLUID RETENTION |
2 |
0.0000 |
| 843 |
BLOOD PRESSURE INCREASED |
6 |
0.0000 |
| 844 |
ERYTHEMA |
8 |
0.0000 |
| 845 |
HYPERHIDROSIS |
5 |
0.0000 |
| 846 |
UNRESPONSIVE TO STIMULI |
1 |
0.0000 |
| 847 |
HAEMATOMA |
1 |
0.0000 |
| 848 |
RESPIRATORY TRACT INFECTION |
1 |
0.0000 |
| 849 |
HAEMORRHAGE |
4 |
0.0000 |
| 850 |
MUCOSAL INFLAMMATION |
1 |
0.0000 |
| 851 |
PARAESTHESIA |
6 |
0.0000 |
| 852 |
DERMATITIS ATOPIC |
2 |
0.0000 |
| 853 |
DEPRESSED MOOD |
2 |
0.0000 |
| 854 |
DEHYDRATION |
5 |
0.0000 |
| 855 |
DRY SKIN |
5 |
0.0000 |
| 856 |
DRUG INEFFECTIVE |
49 |
0.0000 |
| 857 |
PAIN OF SKIN |
1 |
0.0000 |
| 858 |
FREQUENT BOWEL MOVEMENTS |
1 |
0.0000 |
| 859 |
DEVICE DELIVERY SYSTEM ISSUE |
1 |
0.0000 |
| 860 |
TREATMENT FAILURE |
3 |
0.0000 |
| 861 |
FEELING COLD |
1 |
0.0000 |
| 862 |
NECK PAIN |
2 |
0.0000 |
| 863 |
COUGH |
10 |
0.0000 |
| 864 |
INCORRECT DRUG ADMINISTRATION DURATION |
1 |
0.0000 |
| 865 |
RHEUMATOID ARTHRITIS |
4 |
0.0000 |
| 866 |
ANXIETY |
10 |
0.0000 |
| 867 |
RED BLOOD CELL COUNT DECREASED |
1 |
0.0000 |
| 868 |
HERPES ZOSTER |
2 |
0.0000 |
| 869 |
GENERAL PHYSICAL HEALTH DETERIORATION |
4 |
0.0000 |
| 870 |
DYSSTASIA |
1 |
0.0000 |
| 871 |
DRUG EFFECTIVE FOR UNAPPROVED INDICATION |
1 |
0.0000 |
| 872 |
NASAL CONGESTION |
2 |
0.0000 |
| 873 |
LABORATORY TEST ABNORMAL |
1 |
0.0000 |
| 874 |
INAPPROPRIATE SCHEDULE OF PRODUCT ADMINISTRATION |
6 |
0.0000 |
| 875 |
THERAPEUTIC RESPONSE DECREASED |
2 |
0.0000 |
| 876 |
ILL-DEFINED DISORDER |
2 |
0.0000 |
| 877 |
GYNAECOMASTIA |
1 |
0.0000 |
| 878 |
CARDIAC DISORDER |
3 |
0.0000 |
| 879 |
NERVOUS SYSTEM DISORDER |
1 |
0.0000 |
| 880 |
DRUG-INDUCED LIVER INJURY |
1 |
0.0000 |
| 881 |
CYSTITIS |
1 |
0.0000 |
| 882 |
GAIT DISTURBANCE |
6 |
0.0000 |
| 883 |
ALOPECIA |
6 |
0.0000 |
| 884 |
EYE DISORDER |
1 |
0.0000 |
| 885 |
BACK PAIN |
7 |
0.0000 |
| 886 |
EXPIRED PRODUCT ADMINISTERED |
1 |
0.0000 |
| 887 |
INSOMNIA |
8 |
0.0000 |
| 888 |
EYE PRURITUS |
1 |
0.0000 |
| 889 |
TYPE 2 DIABETES MELLITUS |
1 |
0.0000 |
| 890 |
TRANSIENT ISCHAEMIC ATTACK |
1 |
0.0000 |
| 891 |
CEREBROVASCULAR ACCIDENT |
5 |
0.0000 |
| 892 |
MYALGIA |
5 |
0.0000 |
| 893 |
URINARY TRACT INFECTION |
5 |
0.0000 |
| 894 |
SINUSITIS |
3 |
0.0000 |
| 895 |
HAEMOGLOBIN DECREASED |
3 |
0.0000 |
| 896 |
RASH MACULAR |
1 |
0.0000 |
| 897 |
HYPERTENSION |
6 |
0.0000 |
| 898 |
INAPPROPRIATE SCHEDULE OF DRUG ADMINISTRATION |
2 |
0.0000 |
| 899 |
SKIN BURNING SENSATION |
2 |
0.0000 |
| 900 |
WHITE BLOOD CELL COUNT DECREASED |
3 |
0.0000 |
| 901 |
PANIC ATTACK |
1 |
0.0000 |
| 902 |
RESPIRATORY FAILURE |
2 |
0.0000 |
| 903 |
MALAISE |
12 |
0.0000 |
| 904 |
RESTLESSNESS |
1 |
0.0000 |
| 905 |
NASOPHARYNGITIS |
5 |
0.0000 |
| 906 |
EYE SWELLING |
1 |
0.0000 |
| 907 |
THROMBOCYTOPENIA |
3 |
0.0000 |
| 908 |
INTESTINAL OBSTRUCTION |
1 |
0.0000 |
| 909 |
UNEVALUABLE EVENT |
2 |
0.0000 |
| 910 |
COLITIS |
1 |
0.0000 |
| 911 |
DEPRESSION |
6 |
0.0000 |
| 912 |
DISORIENTATION |
1 |
0.0000 |
| 913 |
GASTROOESOPHAGEAL REFLUX DISEASE |
2 |
0.0000 |
| 914 |
PSORIATIC ARTHROPATHY |
1 |
0.0000 |
| 915 |
CARDIAC ARREST |
2 |
0.0000 |
| 916 |
LOSS OF CONSCIOUSNESS |
3 |
0.0000 |
| 917 |
PSORIASIS |
3 |
0.0000 |
| 918 |
INTENTIONAL PRODUCT USE ISSUE |
2 |
0.0000 |
| 919 |
ANGIOEDEMA |
1 |
0.0000 |
| 920 |
GASTROINTESTINAL DISORDER |
2 |
0.0000 |
| 921 |
ADVERSE DRUG REACTION |
2 |
0.0000 |
| 922 |
TINNITUS |
1 |
0.0000 |
| 923 |
UPPER RESPIRATORY TRACT INFECTION |
1 |
0.0000 |
| 924 |
BREAST CANCER |
2 |
0.0000 |
| 925 |
BLOOD CHOLESTEROL INCREASED |
1 |
0.0000 |
| 926 |
FALL |
7 |
0.0000 |
| 927 |
DISEASE RECURRENCE |
1 |
0.0000 |
| 928 |
ANAEMIA |
4 |
0.0000 |
| 929 |
MULTIPLE SCLEROSIS |
1 |
0.0000 |
| 930 |
LOSS OF PERSONAL INDEPENDENCE IN DAILY ACTIVITIES |
1 |
0.0000 |
| 931 |
INTERSTITIAL LUNG DISEASE |
1 |
0.0000 |
| 932 |
PAIN IN EXTREMITY |
6 |
0.0000 |
| 933 |
DRY EYE |
1 |
0.0000 |
| 934 |
NERVOUSNESS |
1 |
0.0000 |
| 935 |
ECZEMA |
1 |
0.0000 |
| 936 |
MUSCULOSKELETAL PAIN |
1 |
0.0000 |
| 937 |
DRUG EFFECT DECREASED |
1 |
0.0000 |
| 938 |
OVERDOSE |
4 |
0.0000 |
| 939 |
TREATMENT NONCOMPLIANCE |
1 |
0.0000 |
| 940 |
DRUG INEFFECTIVE FOR UNAPPROVED INDICATION |
1 |
0.0000 |
| 941 |
TREMOR |
3 |
0.0000 |
| 942 |
MEDICATION ERROR |
1 |
0.0000 |
| 943 |
BLISTER |
1 |
0.0000 |
| 944 |
OXYGEN SATURATION DECREASED |
1 |
0.0000 |
| 945 |
ASTHMA |
2 |
0.0000 |
| 946 |
CONVULSION |
1 |
0.0000 |
| 947 |
LETHARGY |
1 |
0.0000 |
| 948 |
EYE IRRITATION |
1 |
0.0000 |
| 949 |
ARTHRALGIA |
7 |
0.0000 |
| 950 |
OEDEMA PERIPHERAL |
2 |
0.0000 |
| 951 |
RHINORRHOEA |
1 |
0.0000 |
| 952 |
PNEUMONIA |
5 |
0.0000 |
| 953 |
DEVICE EXPULSION |
1 |
0.0000 |
| 954 |
AMNESIA |
1 |
0.0000 |
| 955 |
BLOOD PRESSURE DECREASED |
1 |
0.0000 |
| 956 |
MULTIPLE SCLEROSIS RELAPSE |
1 |
0.0000 |
| 957 |
WEIGHT DECREASED |
4 |
0.0000 |
| 958 |
INJURY |
1 |
0.0000 |
| 959 |
THERAPEUTIC PRODUCT EFFECT INCOMPLETE |
1 |
0.0000 |
| 960 |
MOBILITY DECREASED |
1 |
0.0000 |
| 961 |
AGITATION |
1 |
0.0000 |
| 962 |
BRONCHITIS |
1 |
0.0000 |
| 963 |
HALLUCINATION |
1 |
0.0000 |
| 964 |
CHRONIC KIDNEY DISEASE |
1 |
0.0000 |
| 965 |
ACUTE KIDNEY INJURY |
2 |
0.0000 |
| 966 |
CONFUSIONAL STATE |
2 |
0.0000 |
| 967 |
INFLUENZA LIKE ILLNESS |
1 |
0.0000 |
| 968 |
DRUG ABUSE |
1 |
0.0000 |
| 969 |
RENAL IMPAIRMENT |
1 |
0.0000 |
| 970 |
SKIN EXFOLIATION |
1 |
0.0000 |
| 971 |
BALANCE DISORDER |
1 |
0.0000 |
| 972 |
MYOCARDIAL INFARCTION |
2 |
0.0000 |
| 973 |
MUSCULOSKELETAL STIFFNESS |
1 |
0.0000 |
| 974 |
OROPHARYNGEAL PAIN |
1 |
0.0000 |
| 975 |
DRUG INTOLERANCE |
1 |
0.0000 |
| 976 |
ATRIAL FIBRILLATION |
1 |
0.0000 |
| 977 |
HYPOTENSION |
2 |
0.0000 |
| 978 |
ILLNESS |
1 |
0.0000 |
| 979 |
PLATELET COUNT DECREASED |
1 |
0.0000 |
| 980 |
INFLUENZA |
1 |
0.0000 |
| 981 |
DISEASE PROGRESSION |
1 |
0.0000 |
| 982 |
EMOTIONAL DISTRESS |
1 |
0.0000 |
| 983 |
RENAL FAILURE |
1 |
0.0000 |
| 984 |
INFECTION |
1 |
0.0000 |
| 985 |
HOSPITALISATION |
1 |
0.0000 |
| 986 |
BLOOD GLUCOSE INCREASED |
1 |
0.0000 |
| 987 |
DEATH |
1 |
0.0000 |